Beleodaq
Total Payments
$319,861
Transactions
834
Doctors
570
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $42,225 | 172 | 148 |
| 2019 | $63,482 | 113 | 87 |
| 2018 | $92,437 | 121 | 95 |
| 2017 | $121,717 | 428 | 306 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $228,338 | 19 | 71.4% |
| Consulting Fee | $32,295 | 20 | 10.1% |
| Honoraria | $17,900 | 6 | 5.6% |
| Food and Beverage | $14,728 | 755 | 4.6% |
| Education | $11,683 | 16 | 3.7% |
| Grant | $10,530 | 2 | 3.3% |
| Travel and Lodging | $4,387 | 16 | 1.4% |
Payments by Type
Research
$228,338
19 transactions
General
$91,523
815 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| SPI-BEL-105 | Spectrum Pharmaceuticals Inc. | $83,130 | 0 |
| Bel-502 | Aurobindo Pharma USA, Inc. | $39,407 | 1 |
| SPI-GCF-301 | Spectrum Pharmaceuticals Inc. | $35,663 | 0 |
| IIS-P-BelMel-001 | Spectrum Pharmaceuticals Inc. | $35,000 | 0 |
| SPI-BEL-12-104 | Spectrum Pharmaceuticals Inc. | $16,213 | 0 |
| BEL-107 | Aurobindo Pharma USA, Inc. | $10,426 | 1 |
| SPI-BEL-106 | Spectrum Pharmaceuticals Inc. | $8,500 | 0 |
Top Doctors Receiving Payments for Beleodaq
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Duarte, CA | $190,483 | 31 |
| , MD PHD | Neurology | Santa Monica, CA | $39,407 | 3 |
| , M.D., M.S., F.A.C.P | Internal Medicine | Gilbert, AZ | $12,810 | 15 |
| , M.D | Hematology & Oncology | Cerritos, CA | $10,426 | 1 |
| , M.D | Hematology & Oncology | New York, NY | $10,246 | 2 |
| , MD | Medical Oncology | New Haven, CT | $9,418 | 7 |
| , M.D | Hematology & Oncology | Pittsburgh, PA | $4,161 | 5 |
| , MD | Hematology & Oncology | San Diego, CA | $4,039 | 4 |
| , M.D | Hematology & Oncology | Providence, RI | $2,859 | 4 |
| , MD | Medical Oncology | Saint Louis, MO | $2,833 | 3 |
| , MD | Hematology & Oncology | Los Angeles, CA | $2,189 | 3 |
| , MD | Internal Medicine | Aurora, CO | $1,950 | 1 |
| , M.D | Hematology & Oncology | Salt Lake City, UT | $1,950 | 1 |
| , D.O | Internal Medicine | Omaha, NE | $1,950 | 1 |
| , MD | Medical Oncology | Charlotte, NC | $1,810 | 6 |
| , MD | Medical Oncology | Fort Myers, FL | $1,650 | 1 |
| , MD | Medical Oncology | San Francisco, CA | $1,650 | 1 |
| , M.D | Hematology | Fort Myers, FL | $1,650 | 1 |
| , M.D | Internal Medicine | Sacramento, CA | $1,375 | 1 |
| , M.D | Hematology & Oncology | Charlotte, NC | $1,350 | 1 |
| Amitkumar Mehta | Hematology & Oncology | Birmingham, AL | $1,113 | 2 |
| , M.D | Hematology & Oncology | Miami, FL | $359.11 | 3 |
| , MD | Hematology & Oncology | Shreveport, LA | $345.91 | 2 |
| , M.D | Hematology & Oncology | Philadelphia, PA | $337.50 | 1 |
| , MD | Hematology & Oncology | Kingwood, TX | $254.96 | 2 |
Ad
Manufacturing Companies
- Spectrum Pharmaceuticals Inc. $217,281
- Aurobindo Pharma USA, Inc. $102,580
Product Information
- Type Drug
- Total Payments $319,861
- Total Doctors 570
- Transactions 834
About Beleodaq
Beleodaq is a drug associated with $319,861 in payments to 570 healthcare providers, recorded across 834 transactions in the CMS Open Payments database. The primary manufacturer is Spectrum Pharmaceuticals Inc..
Payment data is available from 2017 to 2020. In 2020, $42,225 was paid across 172 transactions to 148 doctors.
The most common payment nature for Beleodaq is "Unspecified" ($228,338, 71.4% of total).
Beleodaq is associated with 7 research studies, including "SPI-BEL-105" ($83,130).